Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
89.52
+0.19 (0.21%)
Jul 15, 2026, 4:00 PM EDT - Market closed
PBE Holdings Information
PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 5.23%, Amgen at 4.78%, Alnylam Pharmaceuticals at 4.75%, Royalty Pharma at 4.69%, and Regeneron Pharmaceuticals at 4.65%.
Total Holdings
33
Top 10 Percentage
44.32%
Asset Class
Equity
ETF Category
Health
Assets
257.89M
PE Ratio
22.47
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 5.23% |
| 2 | AMGN | Amgen Inc. | 4.78% |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.75% |
| 4 | RPRX | Royalty Pharma plc | 4.69% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 4.65% |
| 6 | BIIB | Biogen Inc. | 4.65% |
| 7 | GILD | Gilead Sciences, Inc. | 4.45% |
| 8 | UTHR | United Therapeutics Corporation | 4.25% |
| 9 | TECH | Bio-Techne Corporation | 3.51% |
| 10 | PTGX | Protagonist Therapeutics, Inc. | 3.35% |
| 11 | VCEL | Vericel Corporation | 3.20% |
| 12 | ILMN | Illumina, Inc. | 3.14% |
| 13 | PTCT | PTC Therapeutics, Inc. | 3.14% |
| 14 | CDNA | CareDx, Inc. | 3.13% |
| 15 | BCRX | BioCryst Pharmaceuticals, Inc. | 3.09% |
| 16 | VCYT | Veracyte, Inc. | 3.03% |
| 17 | ACAD | ACADIA Pharmaceuticals Inc. | 2.93% |
| 18 | INCY | Incyte Corporation | 2.90% |
| 19 | RGEN | Repligen Corporation | 2.89% |
| 20 | SRPT | Sarepta Therapeutics, Inc. | 2.83% |
| 21 | HALO | Halozyme Therapeutics, Inc. | 2.83% |
| 22 | ANAB | AnaptysBio, Inc. | 2.78% |
| 23 | EXEL | Exelixis, Inc. | 2.72% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 2.72% |
| 25 | NBIX | Neurocrine Biosciences, Inc. | 2.71% |
As of Jul 7, 2026